Q1 2022 Holdings
Filed 2022-05-16 | 122 holdings | $414.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Adapthealth Corp(AHCO) | COMMON STOCK | 00653Q102 | $186.8M | 11,650,072 | 45.1% |
| Centene Corp del(CNC) | COM | 15135B101 | $46.6M | 553,800 | 11.3% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $41.3M | 3,594,829 | 10.0% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $37.9M | 5,379,000 | 9.2% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $35.1M | 952,703 | 8.5% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $16.5M | 1,012,000 | 4.0% |
| Alector Inc(ALEC) | COM | 014442107 | $15.0M | 1,055,192 | 3.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $12.0M | 1,601,000 | 2.9% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $8.8M | 584,136 | 2.1% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $3.9M | 375,585 | 0.9% |
| Acutus MED Inc(AFIB) | COM | 005111109 | $3.7M | 2,648,386 | 0.9% |
| Annexon Inc(ANNX) | COM | 03589W102 | $1.6M | 583,913 | 0.4% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $942.0K | 464,252 | 0.2% |
| Glaukos Corp | NOTE 2.750% 6/1 | 377322AB8 | $358.8K | $269,897,000 | 0.1% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $268.6K | 19,341,024 | 0.1% |
| Viatris Inc(VTRS) | COM | 92556V106 | $224.9K | 20,673,700 | 0.1% |
| Invitae Corp | NOTE 2.000% 9/0 | 46185LAB9 | $169.8K | $206,873,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $155.4K | 1,657,800 | 0.0% |
| Aerie Pharmaceuticals Inc | NOTE 1.500%10/0 | 00771VAB4 | $141.9K | $157,390,000 | 0.0% |
| Envista Holdings Corporation | NOTE 2.375% 6/0 | 29415FAB0 | $123.9K | $52,500,000 | 0.0% |
| Caremax Inc | COM CL A | 14171W103 | $121.8K | 15,861,090 | 0.0% |
| Natera Inc | NOTE 2.250% 5/0 | 632307AB0 | $120.2K | $90,638,000 | 0.0% |
| Sarepta Therapeutics Inc | DBCV 1.500%11/1 | 803607AB6 | $116.1K | 88,657,000 | 0.0% |
| Pacira Biosciences Inc | NOTE 0.750% 8/0 | 695127AF7 | $100.9K | $81,600,000 | 0.0% |
| Nuvasive Inc | NOTE 1.000% 6/0 | 670704AL9 | $96.4K | $96,966,000 | 0.0% |
| Pulmonx Corp(LUNG) | COM | 745848101 | $91.7K | 3,695,341 | 0.0% |
| Silk RD MED Inc | COM | 82710M100 | $88.9K | 2,153,712 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $82.3K | 4,891,996 | 0.0% |
| Apellis Pharmaceuticals Inc | NOTE 3.500% 9/1 | 03753UAB2 | $81.7K | $51,885,000 | 0.0% |
| Tabula Rasa Healthcare Inc | NOTE 1.750% 2/1 | 873379AA9 | $79.7K | $107,816,000 | 0.0% |
| Insulet Corp | NOTE 0.375% 9/0 | 45784PAK7 | $76.2K | $57,581,000 | 0.0% |
| Nuvasive Inc | NOTE 0.375% 3/1 | 670704AJ4 | $76.1K | $80,000,000 | 0.0% |
| Insmed Inc | NOTE 1.750% 1/1 | 457669AA7 | $74.9K | $75,000,000 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $72.3K | 3,282,912 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $71.0K | 4,416,361 | 0.0% |
| Nevro Corp | NOTE 2.750% 4/0 | 64157FAC7 | $65.4K | $61,000,000 | 0.0% |
| Organogenesis Hldgs Inc(ORGO) | COM | 68621F102 | $64.4K | 8,456,876 | 0.0% |
| Intercept Pharmaceuticals in | NOTE 3.250% 7/0 | 45845PAA6 | $53.0K | $57,791,000 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $51.7K | 5,580,456 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $48.9K | 465,000 | 0.0% |
| Bridgebio Pharma Inc | NOTE 2.500% 3/1 | 10806XAB8 | $47.4K | $80,000,000 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $45.5K | 765,489 | 0.0% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $45.0K | 134,989 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $42.7K | 4,695,020 | 0.0% |
| Sema4 Holdings Corp(SMFRUSD) | COM CL A | 81663L101 | $42.5K | 13,848,488 | 0.0% |
| Singular Genomics Systems in | COM | 82933R100 | $41.7K | 6,612,019 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $38.2K | 3,933,137 | 0.0% |
| 1Life Healthcare Inc | NOTE 3.000% 6/1 | 68269GAB3 | $34.7K | $40,000,000 | 0.0% |
| The Oncology Institute Inc(TOI) | COM | 68236X100 | $32.1K | 3,296,107 | 0.0% |
| Pharvaris N V(PHVS) | COM | N69605108 | $28.6K | 1,577,078 | 0.0% |